ArticleProtein & cell2014

Dual inhibition of EGFR at protein and activity level via combinatorial blocking of PI4KIIα as anti-tumor strategy.

Jiangmei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.